Bionovis Email Format
Biotechnology ResearchSão Paulo, Brazil201-500 Employees
Bionovis is a 100% Brazilian biotechnology company focused on researching, developing, manufacturing, and commercializing complex biopharmaceuticals of high quality to improve patient outcomes. Situated in the evolving global biopharmaceutical landscape, the company is advancing production of highly complex biological medicines in Brazil. Its development plan includes a pipeline of biosimilars, biobetters, and innovative biopharmaceuticals, supported by capabilities to produce monoclonal antibodies and therapeutic proteins. Its activities are supported by collaborations with global industry leaders and with major national public institutions, aligning its efforts with public health needs. Headquartered in Valinhos, in the São Paulo region, Bionovis is described as a mid-sized enterprise with substantial infrastructure and expertise. In February 2026, the company announced a commitment to the productive development of Pertuzumab, a treatment for HER-2 positive metastatic breast cancer, aimed at serving an estimated 72,000 patients annually.
1-888-653-2347 
support@leadiq.com 
